Organizational Strategy - Sustainable Development - L'Oréal
Organizational Strategy - Sustainable Development - L'Oréal
Organizational Strategy - Sustainable Development - L'Oréal
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5 L’oréaL - GrI DaTa SHEETS 2011<br />
Net profit per share**(e)<br />
2010: €4.01 billion<br />
2011: €4.32 billion<br />
Group share of net profit<br />
2010: €2.2397 billion<br />
2011: €2.4384 billion<br />
Group share of net diluted earnings per share (e)<br />
2010: €3.79 billion<br />
2011: €4.08 billion<br />
Diluted average number of shares<br />
2010: 591,392,449<br />
2011: 597,633,103<br />
* Net profit, excluding non-recurring items, also excludes asset depreciation, restructuring costs, the effects of taxes and minority interests.<br />
** Group share per diluted share, excluding non-recurring items.<br />
The total cost of net financial indebtedness fell strongly again this year and stands at 25.2 million euros. This new reduction results in a<br />
considerable lessening of our average debt.<br />
Dividends from Sanofi rose to 295.6 million euros, up by 4.2%.<br />
Tax on profits, excluding non-recurring items rose to 977.6 million euros, i.e. 27.4%, slightly down on 2010.<br />
The group share of net profit excluding non-recurring items amounted to 2.5829 billion euros, up by 8.9%.<br />
The net profit per share, at €4.32, was up by 7.8%.<br />
For 2011, after taking non-recurring items into account, i.e. a charge, net of taxes amounting to 144 million euros, the net profit is<br />
2.4384 billion euros, up by 8.9%.<br />
CasH FLOW FROM OPeRaTIONs, baLaNCe sHeeT aND DebT<br />
The cash flow from operations was 3.2262 billion euros.<br />
The need for working capital increased by 322 million, following two years when it had reduced in absolute terms. This is a return to a<br />
situation more in line with the changes to group business.<br />
Investments, at 865.7 million euros, amounted to 4.3% of turnover.<br />
after paying a dividend and paying for acquisitions (Q-MED and Clarisonic), the group posted a net cash surplus of 504 million euros.<br />
The balance sheet structure is very solid since, at the end of 2011, own capital made up 65.7% of the assets. The strengthening of own<br />
capital over the 2010 results mainly from the profit allocated to reserves and the net re-valuation of Sanofi securities, valued at market<br />
price.<br />
DIVIDeND PROPOseD TO THe 17 aPRIL 2012 GeNeRaL MeeTING<br />
The Board of Directors has decided to propose to the General Meeting of shareholders on 17 april 2012, approving a dividend of 2 euros<br />
per share, up by 11% compared to the dividend paid in 2011. It will be paid on 3 May 2012 (ex-dividend date 27 april at midnight, Paris time).<br />
2012 is the first year when shareholders who have been continuously registered for more than two years will receive a dividend greater<br />
than 10%.<br />
sHaRe CaPITaL<br />
The Board of Directors recorded that the amount of the share capital as at 31 December 2011 was 602,984,082 shares with a nominal value<br />
of €0.20, i.e. a total of 120,596,816.40 euros.<br />
> For more details, see the 2011 reference Document: Consolidated accounts p.87.<br />
5/14